108 related articles for article (PubMed ID: 32483835)
41. Glycosaminoglycans bind to homologous cardiotoxins with different specificity.
Vyas KA; Patel HV; Vyas AA; Wu W
Biochemistry; 1998 Mar; 37(13):4527-34. PubMed ID: 9521773
[TBL] [Abstract][Full Text] [Related]
42. Interaction of 70-kDa heat shock protein with glycosaminoglycans and acidic glycopolymers.
Harada Y; Garenáux E; Nagatsuka T; Uzawa H; Nishida Y; Sato C; Kitajima K
Biochem Biophys Res Commun; 2014 Oct; 453(2):229-34. PubMed ID: 24909693
[TBL] [Abstract][Full Text] [Related]
43. Expression of externally-disposed heparin/heparan sulfate binding sites by uterine epithelial cells.
Wilson O; Jacobs AL; Stewart S; Carson DD
J Cell Physiol; 1990 Apr; 143(1):60-7. PubMed ID: 2138625
[TBL] [Abstract][Full Text] [Related]
44. Biochemical and functional characterization of glycosaminoglycans released from degranulating rat peritoneal mast cells: Insights into the physiological role of endogenous heparin.
Lever R; Smailbegovic A; Riffo-Vasquez Y; Gray E; Hogwood J; Francis SM; Richardson NV; Page CP; Mulloy B
Pulm Pharmacol Ther; 2016 Dec; 41():96-102. PubMed ID: 27816772
[TBL] [Abstract][Full Text] [Related]
45. Isolation and characterization of glycosaminoglycans from bovine follicular fluid and their effect on sperm capacitation.
Thérien I; Bergeron A; Bousquet D; Manjunath P
Mol Reprod Dev; 2005 May; 71(1):97-106. PubMed ID: 15736127
[TBL] [Abstract][Full Text] [Related]
46. Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27.
Składanowska K; Bloch Y; Strand J; White KF; Hua J; Aldridge D; Welin M; Logan DT; Soete A; Merceron R; Murphy C; Provost M; Bazan JF; Hunter CA; Hill JA; Savvides SN
Cell Rep; 2022 Oct; 41(3):111490. PubMed ID: 36261006
[TBL] [Abstract][Full Text] [Related]
47. The modulation of heparin-like activity of endothelial cells in experimental systems.
Shimada K; Kobayashi M; Ozawa T
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1337-42. PubMed ID: 2629459
[TBL] [Abstract][Full Text] [Related]
48. Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans.
Talaga ML; Fan N; Fueri AL; Brown RK; Bandyopadhyay P; Dam TK
Biochemistry; 2016 Aug; 55(32):4541-51. PubMed ID: 27427828
[TBL] [Abstract][Full Text] [Related]
49. Anticoagulant heparin-like glycosaminoglycans on endothelial cell surface.
Shimada K; Kobayashi M; Kimura S; Nishinaga M; Takeuchi K; Ozawa T
Jpn Circ J; 1991 Oct; 55(10):1016-21. PubMed ID: 1744977
[TBL] [Abstract][Full Text] [Related]
50. Comparisons of the ability of follicular fluid glycosaminoglycans and chemically desulfated heparin to compete for heparin-binding sites on granulosa cells.
Bellin ME; Wentworth BC; Ax RL
Biol Reprod; 1987 Sep; 37(2):293-300. PubMed ID: 2823919
[TBL] [Abstract][Full Text] [Related]
51. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
52. Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix.
Shuvaev VV; Laffont I; Siest G
FEBS Lett; 1999 Oct; 459(3):353-7. PubMed ID: 10526164
[TBL] [Abstract][Full Text] [Related]
53. Glycosaminoglycans exposed on the endothelial cell surface. Binding of heparin-like molecules derived from serum.
Cavari S; Vannucchi S
FEBS Lett; 1993 May; 323(1-2):155-8. PubMed ID: 8495730
[TBL] [Abstract][Full Text] [Related]
54. The Effect of Heparin and Other Exogenous Glycosaminoglycans (GAGs) in Reducing IL-1β-Induced Pro-Inflammatory Cytokine IL-8 and IL-6 mRNA Expression and the Potential Role for Reducing Inflammation.
Jafri M; Li L; Liang B; Luo M
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543157
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of glycosaminoglycans by chick retinal pigment epithelium in vitro.
Chihara E; Tsukada-Fujioka T; Tsukahara I
Graefes Arch Clin Exp Ophthalmol; 1984; 222(1):45-50. PubMed ID: 6439608
[TBL] [Abstract][Full Text] [Related]
56. Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells.
Nader HB; Pinhal MA; Baú EC; Castro RA; Medeiros GF; Chavante SF; Leite EL; Trindade ES; Shinjo SK; Rocha HA; Tersariol IL; Mendes A; Dietrich CP
Braz J Med Biol Res; 2001 Jun; 34(6):699-709. PubMed ID: 11378657
[TBL] [Abstract][Full Text] [Related]
57. Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycans.
Iversen N; Sandset PM; Abildgaard U; Torjesen PA
Thromb Res; 1996 Nov; 84(4):267-78. PubMed ID: 8948051
[TBL] [Abstract][Full Text] [Related]
58. The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils.
Schlorke D; Thomas L; Samsonov SA; Huster D; Arnhold J; Pichert A
Carbohydr Res; 2012 Jul; 356():196-203. PubMed ID: 22444322
[TBL] [Abstract][Full Text] [Related]
59. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.
Warda M; Mao W; Toida T; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047
[TBL] [Abstract][Full Text] [Related]
60. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M
J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
